NTRK3, also named Tropomyosin receptor kinase C (TrkC), is the high affinity catalytic receptor for the neurotrophin and play a major role in neuronal differentiation and survival, the overactivation or overexpression of NTRK3 fusion protein, due to chromosomal rearrangement, was originally found in congenital fibrosarcoma and subsequently found in secretory breast cancer and other type cancer, the identification of NTRK3 fusion genes as driver genes has lead to the rapid development of anticancer therapeutics agents, such as LOXO-101, PF026732240, TSR-011, RXDX-101.
Ba/F3 cell, a murine interleukin-3 dependent pro-B cell line, is a popular system for exploring both kinases and their inhibitors, because some protein kinases can render the Ba/F3 cells to be depended on the activation of the kinases instead of IL-3 supplement, while their inhibitors can antagonize the kinase-dependent growth effects.